Eastgate Biotech Corp. (ETBI)

Eastgate Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	0	-	0.02	0.29	0	0.1
Cash & Short-Term Investments	0	-	0.02	0.29	0	0.1
Cash Growth	-	-	-93.28%	62450.44%	-99.54%	-
Other Receivables	0.03	-	0.08	0.05	-	-
Receivables	0.03	-	0.08	0.05	-	-
Prepaid Expenses	0.02	-	-	-	-	0
Other Current Assets	-	-	0.01	-	-	-
Total Current Assets	0.17	-	0.11	0.34	0	0.1
Property, Plant & Equipment	0.7	-	0.18	0.14	0.07	-
Total Assets	1.67	-	0.3	0.48	0.07	0.1
Accounts Payable	0.65	0.28	0.36	0.3	0.42	0.23
Accrued Expenses	3.13	2.53	1.02	0.57	1.06	0.04
Short-Term Debt	2.7	1.67	1.31	1.01	0.9	0.45
Current Portion of Leases	0.38	0.01	0.01	-	0.02	-
Current Unearned Revenue	-	0.09	0.02	-	-	-
Other Current Liabilities	0.1	0	0	0	-	-
Total Current Liabilities	6.96	4.58	2.73	1.88	2.4	0.71
Long-Term Leases	-	0.04	0.05	-	-	-
Total Liabilities	6.96	4.62	2.78	1.88	2.4	0.71
Common Stock	0.01	0	0	0	0	0
Additional Paid-In Capital	13.22	9.97	9.14	5.96	0.13	0.13
Retained Earnings	-18.4	-14.63	-11.65	-7.37	-2.46	-0.74
Comprehensive Income & Other	-0.12	0.04	0.03	0.02	0	-
Shareholders' Equity	-5.29	-4.62	-2.48	-1.4	-2.33	-0.61
Total Liabilities & Equity	1.67	-	0.3	0.48	0.07	0.1
Total Debt	3.08	1.72	1.37	1.01	0.92	0.45
Net Cash (Debt)	-3.07	-1.72	-1.35	-0.72	-0.92	-0.35
Net Cash Per Share	-0.01	-0.01	-0.01	-0.01	-0.03	-0.01
Filing Date Shares Outstanding	2,058	934.31	282.87	89.64	31.63	31.63
Total Common Shares Outstanding	2,058	309.52	282.87	89.64	31.63	31.63
Working Capital	-6.79	-4.58	-2.62	-1.54	-2.4	-0.61
Book Value Per Share	-0.00	-0.01	-0.01	-0.02	-0.07	-0.02
Tangible Book Value	-5.29	-4.62	-2.48	-1.4	-2.33	-0.61
Tangible Book Value Per Share	-0.00	-0.01	-0.01	-0.02	-0.07	-0.02
Machinery	0.78	-	0.27	0.19	0.02	-

Updated Mar 4, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.